Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy – News-Medical.Net

Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy – News-Medical.Net

Nivolumab has recently been approved both in combination with fluoropyrimidine- and platinum-based combination chemotherapy and in combination with ipilimumab for the first-line treatment of adults w… [read more]

Leave a Reply

Your email address will not be published.